{
    "nctId": "NCT02429765",
    "officialTitle": "Effect of Aclidinium Bromide/Formoterol on Nighttime Lung Function, Respiratory Mechanics and Early Morning Symptoms in Chronic Obstructive Pulmonary Disease (COPD)",
    "inclusionCriteria": "* Moderate to severe COPD (post-bronchodilator forced expiratory volume in 1 s (FEV1) 30-79%predicted);\n* Resting functional residual capacity (FRC) \\>120% predicted;\n* Clinically stable and on stable triple therapy with an ICS/LABA and tiotropium;\n* Symptomatic: Baseline Dyspnea Index \u22648 and answer \"in the morning\" when asked about what time of day their COPD symptoms are worst.\n* Must have minimum age of 40 Years",
    "exclusionCriteria": "* A diagnosis of sleep disordered breathing;\n* Nocturnal oxygen therapy."
}